A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 35 (6), 677-680
- https://doi.org/10.1007/bf00637607
Abstract
We have studied the kinetics of a single oral dose of mefloquine (750 mg) in 12 Thai patients with falciparum malaria and have compared the results with those of a previous study in 12 healthy Thai volunteers [6]. All the patients responded to treatment with a mean parasite clearance time of 66.6 h and a mean fever clearance time of 54.1 h. There was no significant difference in peak plasma concentration, time to peak, area under the curve or apparent volume of distribution between patients and controls. However, the terminal half-life (t1/2) and mean residence time (MRT) were shorter in the patients (12.2 vs 16.7 days for t1/2 and 15.5 vs 21.4 days for MRT). We conclude that there are changes in the disposition of mefloquine related to malaria, although the exact basis of the changes is not clear.This publication has 10 references indexed in Scilit:
- Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers.British Journal of Clinical Pharmacology, 1987
- The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjectsEuropean Journal of Clinical Pharmacology, 1987
- The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.British Journal of Clinical Pharmacology, 1985
- An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.1985
- A phase II clinical trial of mefloquine in Brazilian male subjects.1983
- A phase I clinical trial of mefloquine in Brazilian male subjects.1983
- A PHASE-II CLINICAL-TRIAL OF MEFLOQUINE IN PATIENTS WITH CHLOROQUINE-RESISTANT FALCIPARUM-MALARIA IN THAILAND1983
- PharmacokineticsPublished by Taylor & Francis ,1982
- Single Dose Kinetics of Mefloquine in ManChemotherapy, 1982
- Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090.1975